We are live on ! Find out more
ARLZ

Aralez Pharmaceuticals Inc.
ARLZ

Delisted

ARLZ was delisted on the 20th of August, 2018.

Back to rankings

Fund managers haven’t disclosed any holdings of ARLZ yet.

ARLZ Hedge Fund Activity: Q4 2018 in Review

1 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Aralez Pharmaceuticals Inc. (ARLZ) for Q4 2018, worth a combined $0 — down 100% from $1K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ARLZ and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.

  • 1 institutional investor held Aralez Pharmaceuticals Inc. (ARLZ) as of Q4 2018, down from 4 in Q3 2018.
  • Funds reported $0 of Aralez Pharmaceuticals Inc. stock for Q4 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Aralez Pharmaceuticals Inc. positions in Q4 2018 and 3 closed out, a net change of -3 holders.

Based on aggregated 13F filings for Q4 2018.